DUBLIN--(BUSINESS WIRE)--The "Chitosan Market Research Report by Product (Food Grade, Industrial Grade, and Pharmaceutical Grade), Packaging Material, Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.
The Global Chitosan Market size was estimated at USD 7,202.37 million in 2021, USD 8,114.35 million in 2022, and is projected to grow at a CAGR 12.83% to reach USD 14,867.46 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Cumulative Impact of COVID-19:
The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Chitosan Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others.
Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Market Segmentation & Coverage:
- Based on Product, the market was studied across Food Grade, Industrial Grade, and Pharmaceutical Grade.
- Based on Packaging Material, the market was studied across Glass, Metal, and Paper.
- Based on Application, the market was studied across Agrochemicals, Cosmetics & Personal Care, Food & Beverages, Medical & Pharmaceuticals, and Water Treatment.
- Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa.
Market Dynamics
Drivers
- Unique properties of Chitosan
- Availability of raw material in abundance
- Research and development and emerging applications
Restraints
- Regulations and compliances Related to shrimp farming
Opportunities
- Growing awareness about health globally
- Production of Chitosan from non-aquatic sources
- Applications of Chitosan as a plastic substitute
Challenges
- Patient allergy issues
- Limited stability of Chitosan in some medical applications
Cumulative Impact of COVID-19
Company Usability Profiles:
- Advanced Biopolymers AS
- Bio21 Co., Ltd.
- Dainichiseika Color & Chemicals Mfg. Co. Ltd.
- FMC Corp.
- Golden-Shell Pharmaceutical Co.,Ltd.
- Heppe Medical Chitosan GmbH
- KIMICA Corporation
- KiOmed Pharma
- Kitozyme S.A.
- Koyo Chemical Co., Ltd.
- Ningbo Zhenhai Haixin Biological Products Co. Ltd.
- Nippon Suisan Kaisha, Ltd.
- Panvo Organics Pvt Ltd.
- Primex EHF
- Qingdao Yunzhou Biochemistry Co., Ltd.
- Taizhou City Fengrun Biochemical Co., Ltd.
- Tidal Vision, Inc.
- Tracxn Technologies
- Vietnam Food JSC
- Weifang Haizhiyuan Biological Products Co., Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/8e8c35
